Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-12 6:57 pm Sale |
2023-06-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 0 0.000% |
-6,590,000 (Position Closed) |
Filing History |
| 2023-06-12 5:00 pm Sale |
2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 0 0.000% |
-5,944,252 (Position Closed) |
Filing History |
| 2023-06-08 09:17 am Sale |
2023-06-08 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 1,000 100.000% |
-2,793,113 (-99.96%) |
Filing History |
| 2023-05-02 5:26 pm Sale |
2023-04-18 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Growth Equity Opportunities 17 LLC | 0 0.000% |
-2,488,587 (Position Closed) |
Filing History |
| 2023-04-18 4:30 pm Purchase |
2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 5,944,252 17.900% |
30,000 (+0.51%) |
Filing History |
| 2023-04-17 4:09 pm Unchanged |
2023-04-16 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.400% |
0 (Unchanged) |
Filing History |
| 2023-02-14 1:43 pm Sale |
2022-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 0 0.000% |
-2,570,292 (Position Closed) |
Filing History |
| 2023-02-10 4:17 pm Sale |
2022-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
TPG GP A, LLC | 0 0.000% |
-1,885,939 (Position Closed) |
Filing History |
| 2023-02-08 4:55 pm Purchase |
2023-02-08 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 6,590,000 19.900% |
150,000 (+2.33%) |
Filing History |
| 2023-01-27 4:58 pm Sale |
2023-01-20 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Growth Equity Opportunities 17 LLC | 2,488,587 7.500% |
-504,371 (-16.85%) |
Filing History |
| 2022-11-16 4:45 pm Purchase |
2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
BML Investment Partners, L.P. | 6,440,000 19.400% |
6,440,000 (New Position) |
Filing History |
| 2022-11-16 4:10 pm Sale |
2022-11-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 0 0.000% |
-3,711,286 (Position Closed) |
Filing History |
| 2022-02-25 5:02 pm Purchase |
2022-02-15 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 2,570,292 8.200% |
800,438 (+45.23%) |
Filing History |
| 2022-02-14 4:10 pm Purchase |
2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,711,286 11.800% |
502,525 (+15.66%) |
Filing History |
| 2022-02-14 2:11 pm Purchase |
2021-12-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Samlyn Capital, LLC | 1,769,854 5.600% |
1,769,854 (New Position) |
Filing History |
| 2022-02-11 4:13 pm Purchase |
2022-01-12 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
TPG GP A, LLC | 1,885,939 6.000% |
1,885,939 (New Position) |
Filing History |
| 2021-10-19 5:20 pm Purchase |
2021-10-14 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
Commodore Capital LP | 3,208,761 10.200% |
1,089,516 (+51.41%) |
Filing History |
| 2021-04-09 4:50 pm Sale |
2021-03-31 | 13G | Satsuma Pharmaceuticals, Inc. STSA |
MORGAN STANLEY MS |
577,022 1.800% |
-416,601 (-41.93%) |
Filing History |
| 2021-03-31 08:52 am Purchase |
2021-02-26 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Shin Nippon Biomedical Laboratories Ltd. | 2,794,113 8.900% |
2,794,113 (New Position) |
Filing History |
| 2021-03-15 2:52 pm Purchase |
2021-03-03 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
Growth Equity Opportunities 17 LLC | 2,992,958 9.500% |
2,992,958 (New Position) |
Filing History |